Consultation hotline:
中文
|
English
Home Page
About Us
Company introduction
Leadership team
Investor
Company history
Company culture
Join us
Drug Research And Development
i-CR rug screening platform
Product pipeline
Pre-clinical pipeline
Product & Service
PrimeGro Primary tumor cell culture medium
Clinical drug sensitivity monitoring
Primary tumor cell drug sensitivity detection kit
News
Company news
Relevant reports
Careers
Contact Us
Company news
Related reports
Interview: Detailed explanation of i-CR technology platform, an innovative application in new cancer drug research and development
The entry point of Percans Oncology in the research and development of anti-tumor drugs is to explor...
2020-04-22
View details
Personalized Tumor Drug Susceptibility Testing Platform by Percans Oncology
Percans Oncology has developed i-CR, a personalized drug susceptibility testing platform for the pre...
2018-04-11
View details
Search by tag
financing
i-CR
PrimeGro
CTB-02
Home Page
About Us
Company introduction
Leadership team
Investor
Company history
Company culture
Join us
Drug Research And Development
i-CR rug screening platform
Product pipeline
Pre-clinical pipeline
Product & Service
PrimeGro Primary tumor cell culture medium
Clinical drug sensitivity monitoring
Primary tumor cell drug sensitivity detection kit
News
Company news
Relevant reports
Contact Us
400-164-8199
zkbymed
zkby@zkbymed.com
WeChat official account
Copyright 2015 Beijing zhikangbo Medical Oncology Research Co., Ltd
京ICP备15041820号